Hypertension in Malaysia: An Analysis of Trends From the National Surveys 1996 to 2011

Cho Naing, Peng Nam Yeoh, Victor Nyunt Wai, Ni Ni Win, Lai Pei Kuan, Kyan Aung, Cho Naing, Peng Nam Yeoh, Victor Nyunt Wai, Ni Ni Win, Lai Pei Kuan, Kyan Aung

Abstract

This study aimed to determine trends in prevalence, awareness, and control of hypertension in Malaysia and to assess the relationship between socioeconomic determinants and prevalence of hypertension in Malaysia.The distribution of hypertension in Malaysia was assessed based on available data in 3 National Health and Morbidity Surveys (NHMSs) and 1 large scale non-NHMS during the period of 1996 to 2011. Summary statistics was used to characterize the included surveys. Differences in prevalence, awareness, and control of hypertension between any 2 surveys were expressed as ratios. To assess the independent associations between the predictors and the outcome variables, regression analyses were employed with prevalence of hypertension as an outcome variable.Overall, there was a rising trend in the prevalence of hypertension in adults ≥30 years: 32.9% (30%-35.8%) in 1996, 42.6% (37.5%-43.5%) in 2006, and 43.5% (40.4%-46.6%) in 2011. There were significant increase of 32% from 1996 to 2011 (P < 0.001) and of 29% from 1996 to 2006 (P < 0.05), but only a small change of 1% from 2006 to 2011 (P = 0.6). For population ≥18 years, only a 1% increase in prevalence of hypertension occurred from the 2006 NHMS (32.2%) to the 2011 NHMS (32.7%) (P = 0.25). A relative increase of 13% occurred in those with primary education (P < 0.001) and a 15% increase was seen in those with secondary education (P < 0.001). The rate of increase in the prevalence of hypertension in the population with income level RM 3000-3999 was the highest (18%) during this period. In general, the older age group had higher prevalence of hypertension in the 2006 and 2011 NHMSs. The prevalence peaked at 74.1% among population aged 65 to 69 years in the 2011 NHMS. Both the proportion of awareness and the control of hypertension in Malaysia improved from 1996 to 2006. A change in the control of hypertension was 13% higher in women than in men.The findings suggest that the magnitude of hypertension in Malaysia needs additional attention. Strengthening the screening for hypertension in primary health-care settings in the high-risk groups and frequent health promotion to the community to enhance individual awareness and commitment to healthy living would be of immense value.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Prevalence of hypertension in Malaysia stratified by age groups.

References

    1. James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8). J Am Med Assoc 2014; 311:507–520.
    1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012; 380:2224–2260.
    1. WHO. A Global Brief on Hypertension. Silent Killer, Global Public Health Crisis. 2013; Geneva, Switzerland: WHO,
    1. Picon RV, Fuchs FD, Moreira LB, et al. Trends in prevalence of hypertension in Brazil: a systematic review with meta-analysis. PLoS One 2012; 7:e48255.
    1. Indexmundi Malaysia Demographics Profile, 2014,
    1. Lim TO, Morad Z. Hypertension Study Group. Prevalence, awareness, treatment and control of hypertension in the Malaysian adult population: results from the national health and morbidity survey 1996. Singapore Med J 2004; 45:20–27.
    1. IPH (Institute for Public Health). The Third National Health and Morbidity Survey (NHMS III) 2006. Kuala Lumpur, Malaysia: Ministry of Health; 2008.
    1. IPH (Institute for Public Health). National Health and Morbidity Survey 2011 (NHMS 2011). Kuala Lumpur, Malaysia: Ministry of Health; 2011.
    1. Rampal L, Rampal S, Azhar MZ, et al. Prevalence, awareness, treatment and control of hypertension in Malaysia: a national study of 16,440 subjects. Public Health 2008; 122:11–18.
    1. National Institute for Clinical Excellence. Hypertension: Clinical Management of Primary Hypertension in Adults. London: National Institute for Clinical Excellence; 2011.
    1. National Institute for Health (NIH). The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7). National Institute for Health (NIH), 2004. Available online at: .
    1. Chobanian AV, Bakris GL, Black HR, et al. National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high blood pressure; National high blood pressure education program coordinating committee. Seventh report of the Joint National Committee on Prevention, Detection, evaluation, and treatment of high blood pressure. J Am Med Assoc 2003; 289:2560–2572.
    1. Gurpreet K, Guat HT, Mustapha F, et al. The epidemiology of hypertension in Malaysia: current status. 15th NIH scientific conference, incorporating the NHMS and GATS. 2012 June 12–14, Holiday Villa Subang Jaya 2012;
    1. Ezzati M, Oza S, Danaei G, et al. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hyper-tension in the United States. Circulation 2006; 117:905–914.
    1. Armitage P, Berry G. Automatic selection procedures and colinearity. Statistical Methods in Medical Research. 3rd ed.1994; Oxford, UK: Blackwell Scientific Publications, 321–323.
    1. Kearney PM, Whelton M, Reynolds K, et al. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22:11–19.
    1. Chow CK, Teo KK, Rangarajan S, et al. PURE (prospective urban rural epidemiology) study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high, middle, and low-income countries. J Am Med Assoc 2013; 310:959–968.
    1. Naing C, Aung K. Prevalence and risk factors of hypertension in Myanmar: a systematic review and meta-analysis. Medicine 2014; 93:e100.
    1. Blacher J, Safar ME. Large-artery stiffness, hypertension and cardiovascular risk in older patients. Nat Clin Pract Cardiovasc Med 2005; 2:450–455.
    1. Ma YQ, Mei WH, Yin P, et al. Prevalence of hypertension in Chinese cities: a meta-analysis of published studies. PLoS One 2013; 8:e58302.
    1. Hertz RP, Unger AN, Cornell JA, et al. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med 2005; 165:2098–2104.
    1. Malaysian Government. Principal Statistics of Labor by Gender, Malaysia. Malaysian Government, 1990; 12–13. Available online at: .
    1. Ghazali SM, Seman Z, Cheong KC, et al. Sociodemographic factors associated with multiple cardiovascular risk factors among Malaysian adults. BMC Public Health 2015; 15:68.
    1. EUROASPIRE I II Group (European Action on Secondary Prevention by Intervention to Reduce Events). Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001; 357:995–1001.
    1. MOH (Ministry of Health). Country Health Plan. 10th Malaysian Plan. Malaysia: MOH (Ministry of Health); 2010.
    1. Rehman A, Rahman AR, Rasool AH. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors. J Hum Hypertens 2002; 16:261–266.
    1. 2013; Santulli G, Trimarco B, Iaccarino G. High Blood Press Cardiovasc Prev. 20:5–12.
    1. Lanni F, Santulli G, Izzo R, et al. The Pl (A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. J Hypertens 2007; 25:551–556.
    1. Whelton PK, He J, Appel LJ, et al. National high blood pressure education program coordinating committee. Primary prevention of hypertension: clinical and public health advisory from the national high blood pressure education program. J Am Med Assoc 2002; 288:1882–1888.
    1. Anchala R, Kannuri NK, Pant H, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens 2014; 32:1170–1177.
    1. Corsi DJ, Neuman M, Finlay JE, et al. Demographic and health surveys: a profile. Int J Epidemiol 2012; 41:1602–1613.
    1. Olives C, Myerson R, Mokdad AH, et al. Prevalence, awareness, treatment, and control of hypertension in United States Counties, 2001–2009. PLoS ONE 2013; 8:e60308.
    1. Bramley TJ, Gerbino PP, Nightengale BS, et al. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. Manag Care Pharm 2006; 12:239–245.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa